NASDAQ: TNXP       Tonix Pharm Holdings
Last Price Today's Change   Day's Range   Trading Volume
0.505   +0.029 (6.09%)  0.48 - 0.51  24,924,900


Avg Volume (4 weeks):0
52 Weeks Range:0.48 - 2.12
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Tonix Pharmaceuticals Holding Corp is a clinical-stage pharmaceutical company. The company is focused on delivering an efficacious and safe long-term treatment for PTSD. PTSD is characterized by chronic disability, inadequate treatment options, high utilization of healthcare services, and economic burden. Its product candidate, TNX-102 SL, a proprietary low-dose cyclobenzaprine sublingual tablet, designed for bedtime administration, is in Phase 3 development as a potential treatment for PTSD.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

3923  6050  952  775 

Top 10 Active Counters
 SQQQ 6.46+0.34 
 SPY 458.97-10.47 
 BFRI 7.90+2.68 
 UVXY 21.18+5.77 
 AAL 17.75-1.71 
 VXX 26.16+5.61 
 CCL 17.95-2.21 
 XLF 38.77-1.33 
 AAPL 156.81-5.13 
 TLGT 0.174-0.028